SCHEMBL12811796

SCHEMBL12811796

[O-][S+](CO)Nc1ccccc1-c1ccc2ncc(N3CCCCC3)nc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 1/20 0.43
▸ HCAR2 Q8TDS4 6/20 0.39
▸ PTPN11 Q06124 1/20 0.38
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTR3A P46098 1/20 0.36
▸ HRH4 Q9H3N8 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HCRTR1 O43613 4/20 0.35
▸ HCRTR2 O43614 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12811957 0.83 PIK3CA (0.43) PIK3CAHCAR2PTPN11CNR1NPC1
SCHEMBL12811794 0.79 PTPN11 (0.42) PIK3CAPTPN11CNR1CNR2NPC1
SCHEMBL1441972 0.79 HRH3 (0.47) PIK3CAHCAR2PTPN11ALDH1A1MAPT
SCHEMBL12812410 0.78 PIK3CA (0.44) PIK3CAHCAR2NPC1RAB9AALDH1A1
SCHEMBL1442797 0.78 HPGD (0.50) PIK3CAHCAR2PTPN11CNR1CNR2
SCHEMBL1441751 0.77 PIK3CA (0.51) PIK3CAPTPN11MET
SCHEMBL12812419 0.76 PIK3CA (0.45) PIK3CAHCAR2NPC1RAB9AALDH1A1
SCHEMBL12812034 0.76 PIK3CA (0.43) PIK3CAPTPN11CNR1CNR2NPC1
SCHEMBL1442436 0.75 KDM4E (0.48) PIK3CAPTPN11CNR2NPC1RAB9A
SCHEMBL1442356 0.75 MAPT (0.52) PIK3CAPTPN11NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO disclosed
Send feedback